Home > Compound List > Compound details
23284-25-5 molecular structure
click picture or here to close

tert-butyl[3-(2-chloro-5-methylphenoxy)-2-hydroxypropyl]amine

ChemBase ID: 6408
Molecular Formular: C14H22ClNO2
Molecular Mass: 271.78298
Monoisotopic Mass: 271.13390663
SMILES and InChIs

SMILES:
Clc1c(OCC(O)CNC(C)(C)C)cc(cc1)C
Canonical SMILES:
OC(COc1cc(C)ccc1Cl)CNC(C)(C)C
InChI:
InChI=1S/C14H22ClNO2/c1-10-5-6-12(15)13(7-10)18-9-11(17)8-16-14(2,3)4/h5-7,11,16-17H,8-9H2,1-4H3
InChIKey:
HQIRNZOQPUAHHV-UHFFFAOYSA-N

Cite this record

CBID:6408 http://www.chembase.cn/molecule-6408.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
tert-butyl[3-(2-chloro-5-methylphenoxy)-2-hydroxypropyl]amine
IUPAC Traditional name
bupranolol
Brand Name
Ophtorenin
Adomed
Betadrenol
Synonyms
Bupranololum
Bupranol
Bupranolol
CAS Number
23284-25-5
PubChem SID
160969715
PubChem CID
2475

DATA SOURCES

DATA SOURCES

All Sources Commercial Sources Non-commercial Sources
Data Source Data ID
DrugBank DB08808 external link
PubChem 2475 external link
Data Source Data ID Price

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem ALOGPS 2.1
Acid pKa 14.087501  H Acceptors
H Donor LogD (pH = 5.5) -0.20999743 
LogD (pH = 7.4) 0.6838863  Log P 2.992262 
Molar Refractivity 74.8597 cm3 Polarizability 29.685394 Å3
Polar Surface Area 41.49 Å2 Rotatable Bonds
Lipinski's Rule of Five true 
Log P 3.14  LOG S -3.28 
Solubility (Water) 1.43e-01 g/l 

PROPERTIES

PROPERTIES

Bioassay(PubChem)

DETAILS

DETAILS

DrugBank DrugBank
DrugBank - DB08808 external link
Item Information
Drug Groups approved
Description Bupranolol is a non-selective beta blocker without intrinsic sympathomimetic activity (ISA), but with strong membrane stabilizing activity. Its potency is similar to "propranolol":http://www.drugbank.ca/drugs/DB00571.
Indication Used to manage hypertension and tachycardia. Also used to treat glaucoma.
Pharmacology Bupranolol is a competitive, nonselective beta-blocker similar to propanolol without intrinsic sympathomimetic activity.
Toxicity Symptoms of overdose include bradycardia, cardiac failure, hypotension, and brochospasm.
Affected Organisms
Humans and other mammals
Biotransformation Over 90% undergo first-pass metabolism. The main metabolite is carboxybupranolol, 4-chloro-3-[3-(1,1-dimethylethylamino)-2-hydroxy-propyloxy]benzoic acid, of which 88% are eliminated renally within 24 hours.
Absorption Quickly and completely absorbed from the gut with less than 10% oral bioavailability.
Half Life 2-4 hours
Protein Binding 76%

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
    No data available
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle